Condition: Sickle Cell Disease · Sponsor: Nationwide Children's Hospital
This study is for caregivers of young children with sickle cell disease and adolescents with sickle cell disease who are currently prescribed hydroxyurea and are receiving care at one of the study sites. The study will assess retention and engagement during a pilot randomized control trial comparing video directly observed therapy (VDOT) to attention control. We also hope to understand more about patient and family preferences longer-term adherence monitoring and intervention. Participants will use an electronic adherence monitor (provided by the study team) to measure how often they are taking their hydroxyurea. Participants will also be asked to complete questionnaires throughout the study period to provide information about their expectations for, experience with, and satisfaction with the study materials.
This description comes directly from the study's public registry record.
Susan Creary, MD, MSc · (614) 722-3550 · susan.creary@nationwidechildrens.org
Nate Goldfarb, MPH · (614) 965-4948 · nate.goldfarb@nationwidechildrens.org
Always discuss trial participation with your own doctor first.
| Lurie Children's Hospital | Chicago, Illinois, United States | Not Yet Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
| Hasbro Children's Hospital | Providence, Rhode Island, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06264700